stockrowOscar Health, Inc.
OSCR Healthcare Healthcare Plans
Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024.
- Revenue
- +72.1%
- EPS
- +201.9%
- Free cash flow
- −24.5%
- Total debt
- −37.0%
Quarter to September 2026, against a year earlier
Follow OSCR
Alert me
Oscar Health, Inc. (OSCR) Book value per share
Oscar Health, Inc.'s book value per share at the end of fiscal 2025 was 3.7×, down 11.6% from 4.2× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 7.2×. Over the past ten years it has ranged from 3.6× (fiscal 2023) to 15.3× (fiscal 2020); the current reading is higher than 29% of that period. Oscar Health, Inc. ranks 7th of 12 Healthcare Plans companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 3.7× | (11.60%) |
| FY2024 | 4.2× | 16.26% |
| FY2023 | 3.6× | (13.41%) |
| FY2022 | 4.2× | (46.02%) |
| FY2021 | 7.8× | (49.29%) |
| FY2020 | 15.3× | 26.10% |
| FY2019 | 12.2× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 7.2× | 5.81% |
| Jun 2026 | 6.8× | 21.63% |
| Mar 2026 | 5.6× | 49.58% |
| Dec 2025 | 3.7× | (5.64%) |
| 24 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| ELV Elevance Health, Inc. compare | 207× |
| HUM Humana Inc. compare | 157× |
| MOH Molina Healthcare, Inc compare | 81.2× |
| CNC Centene Corporation compare | 45.1× |
| OSCR Oscar Health, Inc. | 7.2× |
| PGNY Progyny, Inc. compare | 5.4× |
| ALHC Alignment Healthcare, Inc. compare | 1.3× |
| CLOV Clover Health Investments, Corp. compare | 0.7× |
| CI Cigna Group compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on OSCR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement